Manufacturer, Merck & Co. To obtain product information on Gardasil or Silgard directly from the manufacturer, you can visit their website and search for product by name. Visit Merck’s database here.
Gardasil: Supplemental Biologics Licensing Application for Use in Anal Cancer Prevention
VRBPAC Briefing Document Presented by Merck on 17 November 2010 Human papillomaviruses (HPV) cause a significant burden of benign and malignant anogenital disease in men and women. The HPV-related anogenital cancers all develop through a common pathogenetic process of neoplastic change that begins with the necessary event of HPV infection. After cervical cancer, the anogenital […]
PRESCRIBING INFORMATION FOR GARDASIL
INDICATIONS AND USAGE GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine: Cervical, vulvar, and vaginal cancer caused by HPV types 16 and 18 Genital warts (condyloma acuminata) caused by HPV types […]
“Gardasil, One Less Victim of Cervical Cancer?” France says ‘NO’ as they ban Gardasil ads
S.A.N.E.Vax, Inc.
France says the award winning advertising campaign for Gardasil is false and misleading. The Sanevax Team wants to know – Where was the press coverage when this happened? Why did no one break the news to the public?
PRLog
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Jan 04, 2011 – Amidst all of the media hype surrounding HPV vaccines, the traditional press has remained silent on many critical issues, not the least of which occurred on the 31 of August 2010 in France. As of that date, Merck’s marketing partner for the HPV vaccine Gardasil, Sanofli-Pasteur, was officially prohibited from advertising Gardasil for cervical cancer prevention in France.
Gardasil: Merck presents more flawed data – FDA grants extended use
The FDA continues to spark controversy over Merck’s Gardasil vaccine, as they ignore scientific principles to grant approval for extended use as a preventative for anal cancer and anal intraepithelial neoplasm. The SaneVax Team wants to know why. PRLog December 30, 2010 FOR IMMEDIATE RELEASE PRLog (Press Release) – Dec 29, 2010 – Wednesday, December […]